STOCK TITAN
  1. Home
  2. Sec-filings
  3. CNS
  4. [Form 4] COHEN & STEERS, INC. Insider Trading Activity

CNS Director Granted 423 RSUs on 10/01/2025; 1,567 Shares Payable

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

The filing reports that Dolly Lisa, a director of Cohen & Steers, Inc. (CNS), was granted 423 restricted stock units (RSUs) on 10/01/2025. The RSUs were 100% vested on the grant date and are payable in shares on the third anniversary of the grant date, at which time 1,567 shares will be delivered to the reporting person. The reported transaction shows a grant price of $0, and the Form 4 was signed by an attorney-in-fact on 10/03/2025. The report discloses direct beneficial ownership following the transaction as 1,567 shares.

Positive

  • 423 RSUs were granted and reported as 100% vested on 10/01/2025
  • RSU delivery is deferred to the third anniversary, clarifying timing of share issuance

Negative

  • None.
Insider Dolly Lisa
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 423 $0.00 --
Holdings After Transaction: Common Stock — 1,567 shares (Direct)
Footnotes (1)
  1. [object Object]
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Dolly Lisa
(Last) (First) (Middle)
1166 AVENUE OF THE AMERICAS
(Street)
NEW YORK NY 10036
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COHEN & STEERS, INC. [ CNS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 A 423(1) A $0 1,567 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.
Remarks:
/s/ Brian W. Heller, Attorney-in-Fact 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did the Form 4 filed for CNS disclose about Dolly Lisa's transaction?

The Form 4 shows a grant of 423 restricted stock units on 10/01/2025, 100% vested at grant, with 1,567 shares to be delivered on the third anniversary.

Will Dolly Lisa pay for the RSUs reported in the Form 4 (CNS)?

The transaction lists a price of $0, indicating no cash purchase price was reported for the RSUs.

When will the RSUs convert into shares according to the filing?

The RSUs are set to be delivered as shares on the third anniversary of the grant date stated in the filing.

How many shares will Dolly Lisa beneficially own after the reported transaction?

The filing reports 1,567 shares beneficially owned following the reported transaction.

Who signed the Form 4 for the reporting person and when?

The Form 4 was signed by /s/ Brian W. Heller, Attorney-in-Fact on 10/03/2025.